Cantor Fitzgerald raises Rocket Lab stock price target on launch record

Cantor Fitzgerald raised its Rocket Lab price target to $96 from $85 and kept an Overweight rating, citing the company’s launch heritage, three-rocket portfolio, customer diversification, and dedicated launchpads as competitive moats. Rocket Lab also reported Q1 fiscal 2026 revenue of $200.3 million, up 63% year over year and above the $190.9 million consensus, while shares trade at $105.47 near the 52-week high of $105.62. A separate Citizens note lifted its target to $95 from $85, reinforcing the positive analyst backdrop despite valuation concerns.

Analysis

The market is increasingly treating RKLB less like a speculative launch vehicle story and more like an integrated defense-and-space platform with recurring revenue optionality. That matters because the multiple expansion is being driven by durability of execution, not just TAM enthusiasm; once a company is perceived as having “heritage” and infrastructure moats, the buyer base shifts toward longer-duration capital and defense-adjacent holders who tolerate weaker near-term earnings optics. The second-order effect is that a higher valuation here can raise the bar for smaller launch peers that still lack cadence, diversified demand, or repeatable mission success, even if they are growing faster off a lower base.

The main risk is not demand — it’s time. At this price, the market is already discounting a clean ramp in Neutron and continued mix improvement in Space Systems over the next 12-24 months, so any slip in launch cadence, qualification delays, or margin compression will hit the stock harder than an earnings miss would in a normal industrial. The biggest bear case is that the current narrative depends on multiple future milestones landing in sequence; if one is pushed out by a quarter or two, the stock can de-rate quickly because the valuation leaves little room for execution slippage.

The contrarian takeaway is that the “moat” may be partially self-reinforcing: success attracts capital, capital funds more launch frequency and infrastructure, and that in turn deepens the moat. But the flip side is that consensus may be underestimating how much of the move is already tied to sentiment and positioning rather than fundamentals; after a 400%+ run, even a strong quarter can produce a muted reaction if guidance is merely good instead of exceptional. This setup argues for trading around catalysts rather than marrying the name outright here.

Key Decisions for Investors

• Trim/hedge existing RKLB longs into strength; at current levels the asymmetry favors selling upside into catalyst windows and preserving capital for a 15%-20% pullback, where the risk/reward improves materially.
• For tactical upside, buy RKLB call spreads 3-6 months out only on post-earnings weakness; structure for limited premium outlay and target a 2:1 to 3:1 payoff if Neutron-related milestones or guidance inflect higher.
• Pair trade: long RKLB / short a weaker, less differentiated small-cap aerospace/launch peer on a relative basis if you can source borrow; the trade works best over 6-12 months if execution remains clean and the market keeps rewarding “heritage + infrastructure” narratives.
• If holding RKLB outright, use a trailing stop or collar around major catalyst dates; implied expectations are high enough that a single delay can erase several months of gains in days.